Dynamic Whole-body PET/CT Imaging in Clinical Oncology
Launched by VALENTINA GARIBOTTO · May 16, 2024
Trial Information
Current as of February 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving a type of imaging called PET/CT scans for patients with cancer. The goal is to create clear and detailed images of the whole body in a way that can be done quickly and accurately. This could help doctors better understand a patient's condition and make more informed treatment decisions.
To be eligible for this study, participants should be adults aged 65 and older who need a whole-body PET scan for their cancer diagnosis. They must be able to stay still during the imaging process and provide consent to participate. If you join the study, you will undergo a PET/CT scan, which is a procedure that helps visualize how cancer is affecting your body. The trial is currently recruiting participants of all genders, and it’s important to note that younger patients and pregnant women cannot take part in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients clinically indicated for whole-body PET evaluation.
- • 2. Patient must agree to lie still in the camera.
- • 3. Patient must be able to comply with study procedures.
- • 4. Patient must be able to provide informed consent.
- Exclusion Criteria:
- • 1. Patients \< 18 years of age.
- • 2. Pregnant women are excluded.
About Valentina Garibotto
Valentina Garibotto is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a strong focus on ethical practices and compliance, Valentina Garibotto collaborates with leading researchers and healthcare professionals to design, implement, and oversee clinical trials across various therapeutic areas. Her expertise in regulatory affairs and trial management ensures the highest standards of quality and safety, fostering trust and transparency within the research community. Valentina Garibotto is driven by a passion for scientific advancement and a commitment to bringing new therapies to market that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Geneva, , Switzerland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0